{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:47:38Z","timestamp":1777924058671,"version":"3.51.4"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The risk of ischemic stroke and intracerebral hemorrhage (ICH) with intensive lipid control by statins among patients with atrial fibrillation (AF) who require direct oral anticoagulants (DOAC) is unclear. We aimed to determine the risks of ischemic stroke and ICH in AF patients treated with DOAC and statins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods:<\/jats:title>\n                    <jats:p>In a population-based retrospective cohort study, we identified AF patients concurrently on DOAC and statins from 2015 to 2021 in Hong Kong. Primary outcome was ischemic stroke. Secondary outcomes were ICH and death. We correlated study outcomes with low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) as time-varying, continuous variables with restricted cubic spline. In secondary analyses, the risks of study outcomes with statin intensity (low, moderate, high) were determined by multivariable time-dependent marginal structural Cox models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>We identified 32,752 AF patients co-prescribed with DOAC and statins. Lower LDL-C (p\u2009&amp;lt;\u20090.001) and higher HDL-C (p\u2009&amp;lt;\u20090.001) levels were associated with lower risk of ischemic stroke but not significantly associated with ICH. LDL-C of\u2009&amp;lt;1.8\u2009mmol\/L (70\u2009mg\/dL) was not associated with mortality (19.6% vs 18.4%, difference 1.2% [95%\u2009CI \u22120.35 to 2.13]). High-intensity statin was associated with a lower risk of ischemic stroke compared with low-intensity statin (weighted Cox-specific hazard ratio [95%\u2009CI]: 0.82\u2009[0.67\u20130.99], p\u2009=\u20090.040) independent of LDL-C levels. Similar associations were found in 11,444 AF patients with a history of ischemic stroke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion and conclusion:<\/jats:title>\n                    <jats:p>Intensive lipid control by high-intensity statins was associated with a lower risk of ischemic stroke in AF patients who required DOACs and did not appear to increase the risk of ICH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/23969873241272530","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T10:29:36Z","timestamp":1724063376000},"page":"137-144","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Lipid control and stroke risk in atrial fibrillation patients treated with direct oral anticoagulants and statins"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1619-4992","authenticated-orcid":false,"given":"Bonaventure","family":"Ip","sequence":"first","affiliation":[{"name":"Medical Data Analytics Centre, The Chinese University of Hong Kong, Hong Kong SAR, China"},{"name":"Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China"},{"name":"Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry","family":"Yip","sequence":"additional","affiliation":[{"name":"Medical Data Analytics Centre, The Chinese University of Hong Kong, Hong Kong SAR, China"},{"name":"Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trista","family":"Hung","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsz-Fai","family":"Yam","sequence":"additional","affiliation":[{"name":"Medical Data Analytics Centre, The Chinese University of Hong Kong, Hong Kong SAR, China"},{"name":"Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carly","family":"Yeung","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China"},{"name":"Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Wong","sequence":"additional","affiliation":[{"name":"Medical Data Analytics Centre, The Chinese University of Hong Kong, Hong Kong SAR, China"},{"name":"Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Leng","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Mok","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China"},{"name":"Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannie","family":"Soo","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3890-3849","authenticated-orcid":false,"given":"David","family":"Seiffge","sequence":"additional","affiliation":[{"name":"Department of Neurology, Inselspital University Hospital Bern and University of Bern, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2802-1626","authenticated-orcid":false,"given":"Ashkan","family":"Shoamanesh","sequence":"additional","affiliation":[{"name":"Department of Neurology, McMaster University, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China"},{"name":"Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"key":"2026012113071199300_bibr1-23969873241272530","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005460","article-title":"More- versus less-intensive lipid-lowering therapy","volume":"12","author":"Toyota","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026012113071199300_bibr2-23969873241272530","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"2026012113071199300_bibr3-23969873241272530","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/STROKEAHA.121.035846","article-title":"Intracranial hemorrhage in the TST trial","volume":"53","author":"Amarenco","year":"2022","journal-title":"Stroke"},{"key":"2026012113071199300_bibr4-23969873241272530","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.amjmed.2020.08.035","article-title":"LDL cholesterol and ischemic stroke in patients with nonvalvular atrial fibrillation","volume":"134","author":"Omelchenko","year":"2021","journal-title":"Am J Med"},{"key":"2026012113071199300_bibr5-23969873241272530","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/joa3.12652","article-title":"2021 Focused update of the 2017 consensus guidelines of the Asia Pacific heart rhythm society (APHRS) on stroke prevention in atrial fibrillation","volume":"37","author":"Chao","year":"2021","journal-title":"J Arrhythm"},{"key":"2026012113071199300_bibr6-23969873241272530","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1093\/eurheartj\/ehab648","article-title":"Corrigendum\u2009to: 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012113071199300_bibr7-23969873241272530","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jacc.2020.01.052","article-title":"Mobile health technology to improve care for patients with atrial fibrillation","volume":"75","author":"Guo","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026012113071199300_bibr8-23969873241272530","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007444","article-title":"Dyslipidemia and risk of cardiovascular events in patients with atrial fibrillation treated with oral anticoagulation therapy: Insights from the ARISTOTLE (apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation) trial","volume":"7","author":"Pol","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026012113071199300_bibr9-23969873241272530","article-title":"Statin use and stroke rate in older adults with atrial fibrillation: A population-based Cohort Study","volume":"12","author":"Shweikialrefaee","year":"2023","journal-title":"J\u2009Am\u2009Heart\u2009Assoc"},{"key":"2026012113071199300_bibr10-23969873241272530","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1161\/STROKEAHA.122.036889","article-title":"Use of lipid-lowering drugs after intracerebral hemorrhage","volume":"53","author":"Shoamanesh","year":"2022","journal-title":"Stroke"},{"key":"2026012113071199300_bibr11-23969873241272530","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1161\/STROKEAHA.121.034576","article-title":"Lipid-lowering therapy and hemorrhagic stroke risk: comparative meta-analysis of statins and PCSK9 inhibitors","volume":"52","author":"Sanz-Cuesta","year":"2021","journal-title":"Stroke"},{"key":"2026012113071199300_bibr12-23969873241272530","article-title":"Association between statin use and ischemic stroke or major hemorrhage in patients taking dabigatran for atrial fibrillation","volume":"189","author":"Antoniou","year":"2017","journal-title":"CMAJ"},{"key":"2026012113071199300_bibr13-23969873241272530","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/CIRCULATIONAHA.111.060061","article-title":"Use of the cha\u20092\u2009ds\u20092\u2009\u2013vascandHAS-BLED\u2009scores\u2009to\u2009aid\u2009decision\u2009making\u2009for\u2009thromboprophylaxis\u2009in\u2009nonvalvular\u2009atrial\u2009fibrillation and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation","volume":"126","author":"Lane","year":"2012","journal-title":"Circulation"},{"key":"2026012113071199300_bibr14-23969873241272530","volume-title":"Health services","author":"Hksar","year":"2016"},{"key":"2026012113071199300_bibr15-23969873241272530","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.hrthm.2016.03.049","article-title":"Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: a population-wide cohort study","volume":"13","author":"Chan","year":"2016","journal-title":"Heart Rhythm"},{"key":"2026012113071199300_bibr16-23969873241272530","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American college of cardiology\/American heart association task force on practice guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"2026012113071199300_bibr17-23969873241272530","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"2026012113071199300_bibr18-23969873241272530","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2174\/157340311799960690","article-title":"The modification of serum lipids after acute coronary syndrome and importance in clinical practice","volume":"7","author":"Balci","year":"2011","journal-title":"Curr Cardiol Rev"},{"key":"2026012113071199300_bibr19-23969873241272530","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a\u2009report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"2026012113071199300_bibr20-23969873241272530","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamcollsurg.2009.10.021","article-title":"Missing data in the American college of surgeons national surgical quality improvement program are not missing at random: implications and potential impact on quality assessments","volume":"210","author":"Hamilton","year":"2010","journal-title":"J Am Coll Surg"},{"key":"2026012113071199300_bibr21-23969873241272530","volume-title":"Regression","author":"Harrell","year":"2010"},{"key":"2026012113071199300_bibr22-23969873241272530","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a\u2009guideline from the American heart association\/American stroke association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"2026012113071199300_bibr23-23969873241272530","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"key":"2026012113071199300_bibr24-23969873241272530","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/aje\/kwu125","article-title":"Marginal structural Cox models for estimating the association between \u03b2-interferon exposure and disease progression in a multiple sclerosis cohort","volume":"180","author":"Karim","year":"2014","journal-title":"Am J Epidemiol"},{"key":"2026012113071199300_bibr25-23969873241272530","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"2026012113071199300_bibr26-23969873241272530","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-med-051812-145304","article-title":"The antithrombotic effects of statins","volume":"65","author":"Owens","year":"2014","journal-title":"Annu Rev Med"},{"key":"2026012113071199300_bibr27-23969873241272530","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/STROKEAHA.117.019653","article-title":"Role of blood lipids in the development of ischemic stroke and its subtypes: a Mendelian randomization study","volume":"49","author":"Hindy","year":"2018","journal-title":"Stroke"},{"key":"2026012113071199300_bibr28-23969873241272530","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1001\/jama.2017.13883","article-title":"Association between use of non-vitamin K oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation","volume":"318","author":"Chang","year":"2017","journal-title":"JAMA"},{"key":"2026012113071199300_bibr29-23969873241272530","article-title":"Concurrent use of statins decreases major bleeding and intracerebral hemorrhage in non-valvular atrial fibrillation patients taking direct oral anticoagulants-A nationwide cohort study","volume":"9","author":"Wu","year":"2022","journal-title":"Front\u2009Cardiovasc\u2009Med"},{"key":"2026012113071199300_bibr30-23969873241272530","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016506","article-title":"Time-dependent cardiovascular treatment benefit model for lipid-lowering therapies","volume":"9","author":"Khan","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2026012113071199300_bibr31-23969873241272530","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/jnnp-2021-328391","article-title":"Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation","volume":"93","author":"Polymeris","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026012113071199300_bibr32-23969873241272530","first-page":"3641","article-title":"Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the reasons for geographical and racial differences in stroke (REGARDS) study","volume":"39","author":"Penson","year":"2018","journal-title":"Eur\u2009Heart\u2009J"},{"key":"2026012113071199300_bibr33-23969873241272530","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1161\/STROKEAHA.107.493106","article-title":"Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial","volume":"38","author":"Amarenco","year":"2007","journal-title":"Stroke"},{"key":"2026012113071199300_bibr34-23969873241272530","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12944-021-01460-6","article-title":"Malnutrition affects cholesterol paradox in coronary artery disease: a 41,229 Chinese cohort study","volume":"20","author":"Wang","year":"2021","journal-title":"Lipids Health Dis"},{"key":"2026012113071199300_bibr35-23969873241272530","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamacardio.2022.0912","article-title":"Association between high-density lipoprotein cholesterol levels and adverse cardiovascular outcomes in high-risk populations","volume":"7","author":"Liu","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2026012113071199300_bibr36-23969873241272530","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000131517.20177.5a","article-title":"Beneficial cardiovascular pleiotropic effects of statins","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"2026012113071199300_bibr37-23969873241272530","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainres.2019.05.024","article-title":"Direct oral anticoagulants are associated with limited damage of endothelial cells of the blood-brain barrier mediated by the thrombin\/PAR-1 pathway","author":"Puech","year":"2019","journal-title":"Brain Res"},{"key":"2026012113071199300_bibr38-23969873241272530","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209291","article-title":"Reader\u2009response:\u2009association of alternative anticoagulation strategies and outcomes in patients with ischemic stroke while taking a direct oral anticoagulant","volume":"102","author":"Ip","year":"2024","journal-title":"Neurology"},{"key":"2026012113071199300_bibr39-23969873241272530","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/17474930241239523","article-title":"Association of LDL-cholesterol &lt;&lt;1.8\u2009mmol l and statin use with the recurrence of intracerebral hemorrhage","volume":"19","author":"Lee","year":"2024","journal-title":"Int J Stroke"},{"key":"2026012113071199300_bibr40-23969873241272530","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jacc.2007.01.098","article-title":"Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation","volume":"50","author":"Shen","year":"2007","journal-title":"J Am Coll Cardiol"}],"container-title":["European Stroke Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23969873241272530","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/23969873241272530","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/esj\/article-pdf\/10\/1\/137\/64652968\/23969873241272530.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/esj\/article-pdf\/10\/1\/137\/64652968\/23969873241272530.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:07:40Z","timestamp":1769018860000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/esj\/article\/10\/1\/137\/8263605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1177\/23969873241272530","relation":{},"ISSN":["2396-9873","2396-9881"],"issn-type":[{"value":"2396-9873","type":"print"},{"value":"2396-9881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3,1]]},"published":{"date-parts":[[2025,3,1]]}}}